Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2018-10-11 | 2019-06-08 | 63796 |
APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2018-10-19 | 2019-02-06 | 64956 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2019-01-03 | 2019-01-17 | 71148 |
APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2019-01-09 | 2019-02-13 | 71659 |
APO-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2019-02-06 | 2019-04-25 | 74867 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2019-02-06 | 2019-03-07 | 74932 |
APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2019-03-05 | 2019-04-05 | 77875 |
APO-FLUCONAZOLE-150 | 150MG | CAPSULE | Resolved | 2019-03-05 | 2019-04-26 | 77884 |
APO-SERTRALINE | 50MG | CAPSULE | Resolved | 2019-04-04 | 2020-03-27 | 80539 |
APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2019-04-24 | 2019-05-31 | 82334 |
APO-PREGABALIN | 150MG | CAPSULE | Resolved | 2019-05-08 | 2019-06-17 | 83527 |
APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2019-05-15 | 2019-05-25 | 84108 |
APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2019-05-15 | 2019-06-01 | 84112 |
APO-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2019-05-22 | 2019-11-11 | 84532 |
APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2019-05-29 | 2020-03-02 | 85161 |
APO-RIVASTIGMINE | 4.5MG | CAPSULE | Resolved | 2019-06-05 | 2019-10-07 | 85610 |
APO-SERTRALINE | 50MG | CAPSULE | Resolved | 2019-06-05 | 2020-03-09 | 85613 |
APO-RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2019-06-12 | 2019-10-07 | 86336 |
APO-DABIGATRAN | 110MG | CAPSULE | Resolved | 2019-06-26 | 2022-10-07 | 87509 |
APO-RIVASTIGMINE | 6MG | CAPSULE | Resolved | 2019-07-03 | 2019-10-07 | 88360 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-NAPRO-NA | 275MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60657 |
APO-NAPRO-NA DS | 550MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60660 |
APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
APO-NAPROXEN | 250MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60666 |
APO-OLANZAPINE | 10.0MG | TABLET | Discontinued | 2018-09-08 | 2018-12-18 | 60672 |
APO-OXAZEPAM | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-08-30 | 60675 |
APO-OXAZEPAM | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
APO-OXAZEPAM | 30MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60681 |
APO-PAROXETINE | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60684 |
APO PREDNISONE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60699 |
APO-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60708 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |
APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-07-13 | 60758 |
APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60763 |